An experimental Covid-19 treatment pill called molnupiravir being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021. Molnupiravir capsules have to be taken twice a day for five days by adult patients for a course of 10, Morrison said. The drug is expected to be available in Australia by early next year if approved by the country's drug regulator, Morrison said. South Korea, Thailand, Taiwan and Malaysia have all said they are in talks to buy the potential treatment, while the Philippines is running a trial on the pill. Even with the Delta outbreaks, Australia still has relatively low coronavirus numbers, with around 115,800 cases.

Source: Dhaka Tribune October 05, 2021 06:11 UTC